Dam, E.B. (author), Loog, M. (author), Christiansen, C. (author), Byrjalsen, I. (author), Folkesson, J. (author), Nielsen, M. (author), Qazi, A.A. (author), Pettersen, P.C. (author), Garnero, P. (author), Karsdal, M.A. (author) Introduction: At present, no disease-modifying osteoarthritis drugs (DMOADS) are approved by the FDA (US Food and Drug Administration); possibly partly due to inadequate trial design since efficacy demonstration requires disease progression in the placebo group. We investigated whether combinations of biochemical and magnetic resonance imaging ...
journal article 2009
